Ratcliffe Liam

Ratcliffe Liam is listed in filings as Director at OnKure Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 1, 2026, including 3 public disclosures. Recent filings connect the profile to OnKure Therapeutics, Inc. (OKUR), Disc Medicine, Inc. (IRON), and Upstream Bio, Inc. (UPB). The current snapshot covers public activity from Jun 12, 2025 to Apr 1, 2026. Reported amounts are shown as $63.3K to $198.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.